Items where authors include "Latimer, N.R."

Article

Jennings, A.C., Rutherford, M.J., Latimer, N.R. orcid.org/0000-0001-5304-5585 et al. (2 more authors) (2024) Perils of randomised controlled trial survival extrapolation assuming treatment effect waning: why the distinction between marginal and conditional estimates matters. Value in Health, 27 (3). pp. 347-355. ISSN 1098-3015

Latimer, N.R. orcid.org/0000-0001-5304-5585, Dewdney, A. and Campioni, M. (2024) A cautionary tale: an evaluation of the performance of treatment switching adjustment methods in a real world case study. BMC Medical Research Methodology, 24 (1). 17. ISSN 1471-2288

Sweeting, M.J. orcid.org/0000-0003-0980-8965, Rutherford, M.J., Jackson, D. et al. (4 more authors) (2023) Survival extrapolation incorporating general population mortality using excess hazard and cure models: a tutorial. Medical Decision Making, 43 (6). pp. 737-748. ISSN 0272-989X

Bullement, A. orcid.org/0000-0001-7091-0972, Stevenson, M.D., Baio, G. et al. (2 more authors) (2023) A systematic review of methods to incorporate external evidence into trial-based survival extrapolations for health technology assessment. Medical Decision Making, 43 (5). pp. 610-620. ISSN 0272-989X

Morga, A., Latimer, N.R. orcid.org/0000-0001-5304-5585, Scott, M. et al. (3 more authors) (2022) Is intention to treat still the gold standard or should health technology assessment agencies embrace a broader estimands framework? : Insights and perspectives from the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum. Value in Health. ISSN 1098-3015

Latimer, N.R. orcid.org/0000-0001-5304-5585 and Adler, A.I. orcid.org/0000-0002-2797-3385 (2022) Extrapolation beyond the end of trials to estimate long term survival and cost effectiveness. BMJ Medicine, 1. e000094. ISSN 2754-0413

Srivastava, T. orcid.org/0000-0002-5961-9348, Latimer, N.R. orcid.org/0000-0001-5304-5585 and Tappenden, P. orcid.org/0000-0001-6612-2332 (2021) Estimation of transition probabilities for state-transition models : a review of NICE appraisals. PharmacoEconomics, 39 (8). pp. 869-878. ISSN 1170-7690

Adler, A.I. and Latimer, N.R. orcid.org/0000-0001-5304-5585 (2021) Adjusting for nonadherence or stopping treatments in randomized clinical trials. JAMA : the Journal of the American Medical Association, 325 (20). pp. 2110-2111. ISSN 0098-7484

Latimer, N.R. orcid.org/0000-0001-5304-5585, Bhadhuri, A., Alshreef, A.O. et al. (10 more authors) (2021) Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke : an economic evaluation. Clinical Rehabilitation, 35 (5). pp. 703-717. ISSN 0269-2155

Latimer, N.R. orcid.org/0000-0001-5304-5585, Towse, A. and Henshall, C. (2021) Not cost-effective at zero price : valuing and paying for combination therapies in cancer. Expert Review of Pharmacoeconomics & Outcomes Research, 21 (3). pp. 331-333. ISSN 1473-7167

Sullivan, T.R., Latimer, N.R. orcid.org/0000-0001-5304-5585, Gray, J. et al. (3 more authors) (2020) Adjusting for treatment switching in oncology trials: A systematic review and recommendations for reporting. Value in Health, 23 (3). pp. 388-396. ISSN 1098-3015

Bell Gorrod, H. orcid.org/0000-0001-8054-8073, Latimer, N.R., Damian, D. et al. (3 more authors) (2020) Assessing the long-term effectiveness of cladribine vs. placebo in the relapsing-remitting multiple sclerosis CLARITY randomized controlled trial and CLARITY extension using treatment switching adjustment methods. Advances in Therapy, 17 (1). pp. 225-239. ISSN 0741-238X

Thomas, S.A., Drummond, A.E.R., Lincoln, N.B. et al. (15 more authors) (2019) Behavioural activation therapy for post-stroke depression : the BEADS feasibility RCT. Health Technology Assessment, 23 (47). pp. 1-176. ISSN 1366-5278

Latimer, N.R. orcid.org/0000-0001-5304-5585, White, I.R., Abrams, K.R. et al. (1 more author) (2019) Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Statistical Methods in Medical Research, 28 (8). pp. 2475-2493. ISSN 0962-2802

Bell Gorrod, H. orcid.org/0000-0001-8054-8073, Latimer, N.R., Damian, D. et al. (3 more authors) (2019) Impact of non-randomised dropout on treatment switching adjustment in the relapsing-remitting multiple sclerosis CLARITY trial and the CLARITY extension study. Value in Health, 22 (7). pp. 772-776. ISSN 1098-3015

Bullement, A., Latimer, N.R. orcid.org/0000-0001-5304-5585 and Bell Gorrod, H. (2019) Survival extrapolation in cancer immunotherapy: a validation-based case study. Value in Health, 22 (3). pp. 276-283. ISSN 1098-3015

Whitehurst, D.G.T., Latimer, N.R., Kagan, A. et al. (4 more authors) (2018) Developing accessible, pictorial versions of health-related quality of life instruments suitable for economic evaluation: a report of preliminary studies conducted in Canada and the United Kingdom. PharmacoEconomics , 2 (3). pp. 225-231. ISSN 2509-4254

Hernandez-Villafuerte, K., Fischer, A. and Latimer, N.R. orcid.org/0000-0001-5304-5585 (2018) Challenges and methodologies in using progression free survival as a surrogate for overall survival In oncology. International Journal of Technology Assessment in Health Care, 34 (3). pp. 300-316. ISSN 0266-4623

Latimer, N.R. orcid.org/0000-0001-5304-5585, Abrams, K.R., Lambert, P.C. et al. (2 more authors) (2018) Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study. Statistical Methods in Medical Research, 27 (3). pp. 765-784. ISSN 0962-2802

Skaltsa, K., Ivanescu, C., Naidoo, S. et al. (3 more authors) (2017) Adjusting Overall Survival Estimates after Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate Cancer. Targeted Oncology, 12 (1). pp. 111-121. ISSN 1776-2596

Hatswell, A.J., Porter, J., Lee, D. et al. (2 more authors) (2016) The Cost of Costing Treatments Incorrectly: Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight. Value in Health, 19 (8). pp. 1055-1058. ISSN 1098-3015

Thomas, S.A., Coates, E., das Nair, R. et al. (10 more authors) (2016) Behavioural Activation Therapy for Depression after Stroke (BEADS): a study protocol for a feasibility randomised controlled pilot trial of a psychological intervention for post-stroke depression. Pilot and Feasibility Studies, 2 (1).

Latimer, N.R. orcid.org/0000-0001-5304-5585, Bell, H. orcid.org/0000-0001-8054-8073, Abrams, K.R. et al. (2 more authors) (2016) Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy. Cancer Medicine. ISSN 2045-7634

Henshall, C., Latimer, N.R. orcid.org/0000-0001-5304-5585, Sansom, L. et al. (1 more author) (2016) Treatment switching in cancer trials: Issues and proposals. International Journal of Technology Assessment in Health Care, 32 (3). pp. 167-174. ISSN 0266-4623

Latimer, N.R., Henshall, C., Siebert, U. et al. (1 more author) (2016) Treatment Switching: statistical and decision making challenges and approaches. International Journal of Technology Assessment in Health Care, 32 (3). pp. 160-166. ISSN 0266-4623

Monograph

Chang, J.-Y.A. orcid.org/0000-0001-6660-5246, Chilcott, J.B. orcid.org/0000-0003-1231-7817 and Latimer, N.R. orcid.org/0000-0001-5304-5585 (2024) Leveraging real-world data to assess treatment sequences in health economic evaluations: a study protocol for emulating target trials using the English Cancer Registry and US Electronic Health Records-Derived Database. Report. SCHARR HEDS Discussion Papers (24.01). Sheffield Centre for Health and Related Research, University of Sheffield

Latimer, N.R. orcid.org/0000-0001-5304-5585, White, I.R., Abrams, K.R. et al. (1 more author) (2017) Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Report. Health Economics & Decision Science (HEDS) Discussion Paper Series (17.09). ScHARR, University of Sheffield

Latimer, N.R., Abrams, K.R., Lambert, P.C. et al. (2 more authors) (2014) Assessing methods for dealing with treatment crossover in clinical trials: A follow-up simulation study. Discussion Paper. HEDS Discussion Paper Series (14.01). Health Economics and Decision Science, School of Health and Related Research (ScHARR), University of Sheffield , Sheffield.